초록 ▼

A vaginal care composition is introduced directly into the vagina in the form of an ovule, a cream or an ointment or with a tampon or which is brought into a position outside the vagina on a panty liner. The composition comprises viable Lactobacillus or Bifidobacterium microorganisms, non-viable Sac

A vaginal care composition is introduced directly into the vagina in the form of an ovule, a cream or an ointment or with a tampon or which is brought into a position outside the vagina on a panty liner. The composition comprises viable Lactobacillus or Bifidobacterium microorganisms, non-viable Saccharomyces cultures, saccharide(s), vitamin A, and zinc.

대표청구항 ▼

What is claimed is: 1. A method of caring for the vaginal mucosa, comprising administering an effective amount of a composition comprising viable Lactobacillus bifidus, non-viable Saccharomyces cerevisiae, D-alpha-tocopherol, pantothenate, zinc, selenium, and oligofructose. 2. The method accordin

What is claimed is: 1. A method of caring for the vaginal mucosa, comprising administering an effective amount of a composition comprising viable Lactobacillus bifidus, non-viable Saccharomyces cerevisiae, D-alpha-tocopherol, pantothenate, zinc, selenium, and oligofructose. 2. The method according to claim 1, wherein the composition is applied directly to the vaginal mucosa. 3. The method according to claim 1, wherein the selenium includes yeast having from 0.001 to 0.06 wt. % selenium. 4. The method according to claim 1, wherein the composition additionally comprises fragrances. 5. The method according to claim 1, wherein the composition further comprises cocoa butter or a hard-fat carrier as a base. 6. The method according to claim 1, wherein the zinc is in the form of zinc sulfate or zinc gluconate. 7. The method according to claim 1, wherein the composition further comprises retinyl acetate, melaleuca aetheroleum, camomile flower extract and lavender oil. 8. The method according to claim 7, wherein the lavender oil is present in an amount of from 0.5 to 10 wt. % . 9. The method according to claim 1, wherein the composition is administered in the form of a care cream. 10. The method according to claim 9, wherein the care cream comprises: from 107 to 109 Lactobacillus bifidus microorganisms/g, from 1 to 10 wt. % Saccharomyces cerevisiae, from 0.05 to 0.3 wt. % vitamin A, from 1 to 3 wt. % D-alpha-tocopherol, from 0.4 to 1.5 wt. % pantothenate, from 1 to 6 wt. % zinc, from 1 to 5 wt. % Melaleuca aetheroleum, from 0.05 to 3 wt. % camomile flower extract, from 2 to 20 wt. % oligofructose or from 1 to 5 wt. % lavender oil. 11. The method according to claim 9, wherein the care cream further comprises constituents selected from the following group: sunflower oil, Tegomuls 90 S, cetyl alcohol, Cetaceum artificiale, Polysorbat 80, methyl 4-hydroxybenzoate, propyl 4-hydroxybenzoate, sesame oil, wool wax, yellow wax, wool wax alcohols, glycerol, glycerol esters, palmitic acid ester, white Vaseline, liquid wax, olive oil and distilled water. 12. The method according to claim 1, wherein the composition is administered in the form of an ovule. 13. The method according to claim 12, wherein the ovule has a weight of 3 g, and a composition of the following: from 107to 109, Lactobacillus bifidus microorganisms/g, from 1 to 10 wt. % Saccharomyces cerevisiae, from 0.05 to 0.3 wt. % vitamin A, from 1 to 3 wt. % D-alpha-tocopherol, from 0.4 to 1.5 wt. % pantothenate, from 0.5 to 5 wt. % zinc, from 0.002 to 0.02 wt. % selenium, from 1 to 5 wt. % Melaleuca aetheroleum, from 1 to 5 wt. % lavender oil, from 0.2 to 3 wt. % camomile flower oil extract, and from 2 to 20 wt. % oligofructose. 14. The method according to claim 12, wherein the ovule is composed of coconut oil, glycerol-gelatin or polyethylene glycol. 15. The method according to claim 12, wherein the ovule further comprises cocoa butter or hard fats. 16. The method according to claim 1, wherein the composition is administered in the form of a panty liner. 17. The method according to claim 16, wherein the panty liner contains from 2 to 5 g of the composition and the composition comprises: from 107 to 109 Lactobacillus bifidus microorganisms/g, from 1 to 10 wt. % Saccharomyces cerevisiae, from 0.05 to 0.3 wt. % retinol acetate, from 1 to 3 wt. % D-alpha-tocopherol, from 1 to 6 wt. % zinc and from 2 to 20 wt. % oligofructose. 18. The method according to claim 16, wherein the composition is applied to an upper layer of the panty liner by a spraying process or one or more further layers are provided therewith. 19. The method according to claim 16, wherein the composition is activated by moisture. 20. The method according to claim 16, wherein the panty liner has a cover layer, a liquid-repelling layer, a storage layer and a backing layer. 21. The method according to claim 20, wherein the composition is contained solely in a layer directly beneath the cover layer of the panty liner. 22. The method according to claim 1, wherein the composition is administered in the form of a vaginal tampon. 23. The method according to claim 22, wherein the tampon contains from 2 to 4 g of the composition and the composition comprises: from 107 to 109 Lactobacillus bifidus microorganisms/g, from 1 to 10 wt. % Saccharomyces cerevisiae, from 0.05 to 0.3 wt. % retinol acetate, from 1 to 3 wt. %, D-alpha-tocopherol, from 1 to 6 wt. % zinc, from 1 to 5 wt. % Melaleuca aetheroleum or from 2 to 20 wt. % oligofructose. 24. The method according to claim 22, wherein the tampon has a liquid-repellent outer layer and an inner storage layer. 25. The method according to claim 22, wherein the composition is applied to a superficial layer of the tampon by spraying or immersing processes or the composition penetrates the entire tampon. 26. The method according to claim 22, wherein the composition is contained solely in a layer directly beneath an outer cover layer of the tampon. 27. The method according to claim 22, wherein the composition is activated by moisture.